Assignee
BIO TECHNOLOGY GENERAL CORP
US·68 granted patents·1,537 citations·filing 1984–1999
Top patents by PatentIndex Score
68 records- 0192US4784990AHigh molecular weight sodium hyaluronateBIO TECHNOLOGY GENERAL CORP·Filed 1985·Granted Nov 15, 1988·144 cites·1 claims
- 0291US5457042ASod polypeptide analogsBIO TECHNOLOGY GENERAL CORP·Filed 1992·Granted Oct 10, 1995·89 cites·7 claims
- 0391US5143836APlasmids for expression of human superoxide dismutase (SOD) analogs containing lambda pl promoter with engineered restriction site for substituting ribosomal binding sites and methods of use thereofBIO TECHNOLOGY GENERAL CORP·Filed 1988·Granted Sep 1, 1992·93 cites·15 claims
- 0489US5455029ATherapeutic compositions comprising a mixture of human CuZn superoxide dismutase analogsBIO TECHNOLOGY GENERAL CORP·Filed 1992·Granted Oct 3, 1995·114 cites·15 claims
- 0587US5965383AFibrin binding domain polypeptides and uses and methods of producing sameBIO TECHNOLOGY GENERAL CORP·Filed 1995·Granted Oct 12, 1999·64 cites·21 claims
- 0687US4871835AAnalogs of hGH having antagonistic activity, and uses thereofBIO TECHNOLOGY GENERAL CORP·Filed 1985·Granted Oct 3, 1989·29 cites·3 claims
- 0786US6030611ATherapeutic SOD compositions and uses thereofBIO TECHNOLOGY GENERAL CORP·Filed 1995·Granted Feb 29, 2000·93 cites·4 claims
- 0886US4784991AHeavy metal salts of hyaluronic acid and their use as antimicrobial agentsBIO TECHNOLOGY GENERAL CORP·Filed 1987·Granted Nov 15, 1988·38 cites·2 claims
- 0985US4780414AMethod of producing high molecular weight sodium hyallronate by fermentation of streptococcusBIO TECHNOLOGY GENERAL CORP·Filed 1986·Granted Oct 25, 1988·88 cites·38 claims
- 1084US4742004AMethod for producing enzymatically active eucaryotic sod in bacteriaBIO TECHNOLOGY GENERAL CORP·Filed 1984·Granted May 3, 1988·30 cites·15 claims
- 1181US4997916AMethod for recovering a purified animal growth hormone or polypeptide analog thereof from a bacterial cellBIO TECHNOLOGY GENERAL CORP·Filed 1989·Granted Mar 5, 1991·16 cites·20 claims
- 1280US6001604ARefolding of proinsulins without addition of reducing agentsBIO TECHNOLOGY GENERAL CORP·Filed 1997·Granted Dec 14, 1999·35 cites·13 claims
- 1380US4746504AHeavy metal salts of hyaluronic acid and their use as antimicrobial agentsBIO TECHNOLOGY GENERAL CORP·Filed 1986·Granted May 24, 1988·63 cites·22 claims
- 1479US5162217APlasmids for expression of human superoxide dismutase (SOD) analogs containing lambda PL promoter with engineered restriction site for substituting ribosomal binding sites and methods of use thereofBIO TECHNOLOGY GENERAL CORP·Filed 1989·Granted Nov 10, 1992·38 cites·20 claims
- 1577US6121426AFibrin binding domain polypeptides and uses and methods of producing sameBIO TECHNOLOGY GENERAL CORP·Filed 1997·Granted Sep 19, 2000·37 cites·8 claims
- 1676US4831120AMethod for recovering a purified animal growth hormone or polypeptide analog thereof from a bacterial cellBIO TECHNOLOGY GENERAL CORP·Filed 1985·Granted May 16, 1989·14 cites·11 claims
- 1775US5948668AProduction of enzymatically active recombinant carboxypeptidase BBIO TECHNOLOGY GENERAL CORP·Filed 1997·Granted Sep 7, 1999·48 cites·9 claims
- 1873US6211341B1Polypeptide having factor Xa inhibitory activityBIO TECHNOLOGY GENERAL CORP·Filed 1999·Granted Apr 3, 2001·26 cites·14 claims
- 1971US5525472AMethod for production and purification or recombinant Apolipoprotein E from bacteriaBIO TECHNOLOGY GENERAL CORP·Filed 1994·Granted Jun 11, 1996·46 cites·6 claims
- 2070US4837155AMethod of growing trichodermaBIO TECHNOLOGY GENERAL CORP·Filed 1987·Granted Jun 6, 1989·25 cites·31 claims
- 2167US5763215AMethod of removing N-terminal amino acid residues from eucaryotic polypeptide analogs and polypeptides produced therebyBIO TECHNOLOGY GENERAL CORP·Filed 1995·Granted Jun 9, 1998·26 cites·3 claims
- 2266US5849702ACloning and production of human von Willebrand factor GPIB binding domain polypeptides and methods of using sameBIO TECHNOLOGY GENERAL CORP·Filed 1995·Granted Dec 15, 1998·15 cites·27 claims
- 2366US5540911AMethods of use of human manganese superoxide dismutaseBIO TECHNOLOGY GENERAL CORP·Filed 1995·Granted Jul 30, 1996·17 cites·4 claims
- 2466US5182113AFactor xa inibitor from leech and pharmaceutical compositions containing sameBIO TECHNOLOGY GENERAL CORP·Filed 1989·Granted Jan 26, 1993·12 cites·9 claims
- 2562US5945304AExpression plasmids regulated by an osmB promoterBIO TECHNOLOGY GENERAL CORP·Filed 1997·Granted Aug 31, 1999·11 cites·11 claims
- 2662US5270030AFibrin binding domain polypeptide and method of producingBIO TECHNOLOGY GENERAL CORP·Filed 1990·Granted Dec 14, 1993·19 cites·15 claims
- 2761US5783421ADNA encoding novel polypeptide having Factor Xa inhibitory activityBIO TECHNOLOGY GENERAL CORP·Filed 1995·Granted Jul 21, 1998·8 cites·22 claims
- 2858US5837488ACloning and production of human von Willebrand Factor GP1b binding domain polypeptides and methods of using sameBIO TECHNOLOGY GENERAL CORP·Filed 1995·Granted Nov 17, 1998·18 cites·6 claims
- 2957US5795776AExpression plasmids regulated by an OSMB promoterBIO TECHNOLOGY GENERAL CORP·Filed 1994·Granted Aug 18, 1998·15 cites·23 claims
- 3056USRE35724EContraception system and methodBIO TECHNOLOGY GENERAL CORP·Filed 1995·Granted Feb 3, 1998·19 cites·28 claims
- 3154US6008193AMethods of using human von Willebrand factor GPIb binding domain polypeptidesBIO TECHNOLOGY GENERAL CORP·Filed 1995·Granted Dec 28, 1999·10 cites·4 claims
- 3254US5637495APlasmids for production of human growth hormone or polypeptide analog thereof, hosts containing the plasmids, products manufactured thereby, and related methodsBIO TECHNOLOGY GENERAL CORP·Filed 1994·Granted Jun 10, 1997·11 cites·4 claims
- 3353US6576659B1Use of oxandrolone in the treatment of burns an other woundsBIO TECHNOLOGY GENERAL CORP·Filed 1997·Granted Jun 10, 2003·9 cites·20 claims
- 3453US5548068ASomatotropins with alterations in the alpha-helix 1 region, and combinations with other mutationsBIO TECHNOLOGY GENERAL CORP·Filed 1994·Granted Aug 20, 1996·12 cites·12 claims
- 3553US5246847APolypeptide analogs of human manganese superoxide dismutase and compositions and complexes thereofBIO TECHNOLOGY GENERAL CORP·Filed 1992·Granted Sep 21, 1993·13 cites·5 claims
- 3651US5679320AFibrin binding domain polypeptides and uses and methods of producing sameBIO TECHNOLOGY GENERAL CORP·Filed 1994·Granted Oct 21, 1997·14 cites·13 claims
- 3751US5116616AUse of intratracheal administration of SOD to protect humans from lung injury due to hyperoxia and hyperventilationBIO TECHNOLOGY GENERAL CORP·Filed 1991·Granted May 26, 1992·19 cites·10 claims
- 3850US5670371ABacterial expression of superoxide dismutaseBIO TECHNOLOGY GENERAL CORP·Filed 1995·Granted Sep 23, 1997·6 cites·2 claims
- 3949US6670351B1Method for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1BIO TECHNOLOGY GENERAL CORP·Filed 1999·Granted Dec 30, 2003·10 cites·36 claims
- 4048US5455158AFibrin binding domain polypeptides and uses and methods of producing sameBIO TECHNOLOGY GENERAL CORP·Filed 1993·Granted Oct 3, 1995·9 cites·8 claims
- 4147US5593860AExpression plasmids containing the deo promoter, and bacterial hosts containing the plasmidsBIO TECHNOLOGY GENERAL CORP·Filed 1994·Granted Jan 14, 1997·8 cites·39 claims
- 4247US5256546ABacterial expression of porcine growth hormoneBIO TECHNOLOGY GENERAL CORP·Filed 1992·Granted Oct 26, 1993·13 cites·12 claims
- 4347US5242812AMethod for production and purification of hepatitis B vaccineBIO TECHNOLOGY GENERAL CORP·Filed 1991·Granted Sep 7, 1993·15 cites·43 claims
- 4446US6010875AExpressions plasmids containing the deo promoter, and bacterial hosts containing the plasmidsBIO TECHNOLOGY GENERAL CORP·Filed 1996·Granted Jan 4, 2000·4 cites·63 claims
- 4546US5147789AStabilized expression vectors containing lambda pl promoter and the gene for the CI434 repressor, plasmids containing the vectors, hosts containing the plasmids and related methodsBIO TECHNOLOGY GENERAL CORP·Filed 1991·Granted Sep 15, 1992·10 cites·14 claims
- 4644US6054291AExpression vectors for enhanced production of polypeptides, plasmids containing the vectors, hosts containing the plasmids, products manufactured thereby and related methodsBIO TECHNOLOGY GENERAL CORP·Filed 1997·Granted Apr 25, 2000·4 cites·5 claims
- 4744US5858970APolypeptide having Factor Xa inhibitory activityBIO TECHNOLOGY GENERAL CORP·Filed 1997·Granted Jan 12, 1999·2 cites·9 claims
- 4843US6090799AMethod for ameliorating muscle weakness/wasting in a patient infected with human immunodeficiency virus-type 1BIO TECHNOLOGY GENERAL CORP·Filed 1993·Granted Jul 18, 2000·8 cites·8 claims
- 4943US5126252AExpressions vectors containing Lambda PL promoter and T1 T2 RNA termination sequence, plasmids containing the vectors, hosts containing the plasmids and relatedmethodsBIO TECHNOLOGY GENERAL CORP·Filed 1989·Granted Jun 30, 1992·4 cites·9 claims
- 5042US5849536ACloning and production of human von willebrand factor GPIb binding domain polypeptides and methods of using sameBIO TECHNOLOGY GENERAL CORP·Filed 1994·Granted Dec 15, 1998·7 cites·24 claims
Showing the top 50 of 68 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →